Ultrasound Detection of Epicardial Adipose Tissue Combined With Ischemic Modified Albumin in the Diagnosis of Coronary Heart Disease
Keywords:Coronary heart disease, echocardiography, epicardial adipose tissue, ischemic modified albumin, joint diagnosis
Objective: To evaluate the value of epicardial adipose tissue (EAT) thickness combined with serum ischemic modified albumin (IMA) concentration in the diagnosis of coronary heart disease.
Methods: A total of 180 patients with coronary heart disease from May 2017 to December 2018 were selected as the case group. After the examination of Judkins coronary angiography, they were grouped according to the results of angiography, including 60 patients in a single-vessel group,
60 patients in a double-vessel group, and 60 patients in a multi-vessel group. Sixty healthy people with physical examinations at our hospital at the same time were selected as the control group. All selected participants were tested for epicardial adipose tissue thickness by echocardiography and serum IMA concentration by albumin cobalt ion binding test.
Results: The EAT thickness and IMA concentration in the single-vessel disease group, double-vessel disease group, and multi-vessel disease group significantly were higher than those in the control group (P < .01). The ROC curve shows that the sensitivity is 53.33% and the specificity is 87.6%, when the EAT thickness is 6.12 mm. The sensitivity is 76.0% and the specificity is 72.3%, when the serum IMA concentration is 72 U/L. When the two were combined, the sensitivity was 40.15% and the specificity was 96.89%. In the parallel test, the sensitivity was 88.3% and the specificity was 65.44%.
Conclusion: Ultrasound detection of EAT thickness and serum IMA concentration has certain reference value for the diagnosis of coronary heart disease. Combined diagnosis can significantly improve the diagnosis rate and accuracy of coronary heart disease.
Faghihi S, Vasheghani-Farahani A, Parsaee M, et al. 2015. Association between epicardial fat thickness and premature coronary artery disease: a case control study . Res Cardiovasc Med 23, 4(2): e25679.
Falkner B, Lurbe E, Schaefer F, el a1. 2010. High blood pressure in childrenren: clinical and health policy implications. J Clin Hypertens 12(4): 261-27.
Gurumurthy P, Borra SK, Yeruva RK, et al. 2014. Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome. Indian J Clin Biochem 29(3): 367-371.
Li J, Guo Q, Zhao J, et al. 2015. Correlation between epicardial fat density and coronary plaque. Chinese Journal of Clinical Medical Imaging 26(3): 179-182.
Mazzali G, Fantin F, Zoico E, et al. 2015. Heart fat infiltration in subjects with and without coronary artery disease. Clin Endocrinol Metab 100(9): 3364-3371.
Song X, Lu S. 2008. Evidence-based evaluation of the value of ischemic modified albumin in the diagnosis of myocardial ischemia in patients with coronary heart disease. Chinese Journal of Evidence-based Cardiovascular Medicine 1(1): 49-52.
Wang H. 2010. Vascular medicine: vascular health assessment and comprehensive prevention and treatment of vascular diseases. Chinese Journal of Medicine 90(30): 2092-2093.
Wang P, Zheng X, Wang Y. 2015. Relationship between serum ischemic modified albumin level and coronary artery lesions in patients with acute coronary syndrome. Chinese Journal of Evidence-based Cardiovascular Medicine 7(5): 650- 651.
Wang T, Liu Q, Pu Y, et al. 2014. Predictive value of epicardial adipose tissue for coronary heart disease. Chinese Journal of Arteriosclerosis 22(1): 61-64.
Xia H, Deng Y, Yang H, et al. 2011. Correlation analysis of high frequency ultrasound measurement of epicardial adipose tissue thickness and coronary heart disease risk factors. Chinese Journal of Ultrasonography 20(3): 197-200.
Yan H, Tang Y, Xu J. 2016. Clinical analysis of non-invasive detection of coronary atherosclerosis. Chinese Journal of Evidence-based Cardiovascular Medicine 8(8): 992-994.
Yuan C, Su Y, Ye S. 2014. Echocardiographic determination of epicardial fat thickness in the diagnosis of coronary heart disease. Clinician Medical Engineering, 21(6): 685-686.